CSF Biomarkers and Alzheimer Disease: Ready for the Clinic?
Here: an update on the current state of CSF fluid-borne markers for Alzheimer disease and what they may portend.
Managing Psychosis in Patients With Alzheimer Disease
Alzheimer disease psychosis appears to be a distinct clinical entity. This article focuses on management strategies.
Vitamin E Slows Functional Decline in Alzheimer Patients
Vitamin E given daily was effective in slowing patients’ functional decline and in reducing caregiver time.
Omega-3 May Protect Against Alzheimer Disease
Omega-3 fatty acids in dietary supplements can cross the blood-brain barrier in persons who have Alzheimer disease, affecting known markers for the disease and for inflammation, a study shows.
Use Peanut Butter to Sniff Out Early Alzheimer Disease?
Peanut butter and a ruler may turn out to be tools that offer an inexpensive, sensitive, and specific olfactory means of screening for Alzheimer disease. Details here.
CMS’s Final Ruling on Amyvid: Limited Coverage
Insufficient evidence proving benefit of Alzheimer’s drug Amyvid behind Medicare’s ruling to limit or deny coverage.
Is Screening for Pre-dementia a Good Idea?
The drive to screen older persons for minor memory changes is leading to unnecessary investigation and potentially harmful treatment, according to some experts.
By clicking Accept, you agree to become a member of the UBM Medica Community.